Newsletter | April 16, 2025

04.16.25 -- Britney Spears/ Take On mRNA Platform Analytics

SPONSOR

Join Advancing RNA Live for a dynamic discussion on the latest regulatory guidances from global agencies and what they mean for mRNA vaccine and therapeutic development. Discover key challenges, actionable insights, and best practices to accelerate your programs—no matter your approach. Don’t miss this opportunity to gain expert-driven clarity. Registration is free thanks to the support of Roche CustomBiotech.

FEATURED EDITORIAL

Britney Spears' Take On Building Platform Analytics For mRNA Therapeutics

As many of the presentations throughout the two-day USP quality forum revealed, we’re doing what we must to establish a future in which we can rely upon platform analytical procedures and — channeling our inner Britney Spears — say “[Ooo], I did it again!” to the regulatory agencies for each of the subsequent molecules in our pipelines.  

MHRA Issues New Regulation On Modular & POC Manufacture Of ATMPs

The U.K.'s MHRA has issued a new regulation to allow for decentralized manufacturing of cell and gene therapies (advanced therapeutic medicinal products), describing modular and point of care manufacturing. It becomes effective July 23, 2025.

INDUSTRY INSIGHTS

Biopharma Production And Quality Control With Electrophoresis

Discover how Kaneka Eurogentec, a leading provider of custom DNA synthesis and molecular biology service, enhanced their fragment analysis to achieve higher efficiency and accuracy in their workflows.

The Next Generation Of mRNA Products: Implications For Quality Control

To fully realize the potential of mRNA as a therapeutic or vaccine modality, developers will need to employ cutting-edge analytical methods to ensure the safety and efficacy of these novel products.

The Key To Accelerating RNA-LNP Drug Development

Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.

Exploring RNA Structure And Ligand Interactions With MMS

Learn about using micropholytic modulation spectroscopy (MMS) to probe RNA base pair and ligand interactions in solution. This research explores the effects of lipid adducts on RNA structure and characterizes base pairing with MMS.

CRISPR Off-Target Editing: Prediction, Analysis, And More

A crucial consideration for researchers is off-target editing – unintended DNA modifications at sites other than the intended target. Explore the complexities and strategies to mitigate these effects.

SPONSOR

TIDES USA 2025

How are industry pioneers accelerating the next wave of therapeutic breakthroughs? Find out at TIDES USA 2025—USA's premier forum for oligonucleotide, peptide, mRNA, genome editing, and drug delivery innovations. May 19-22, 2025 @ Manchester Grand Hyatt San Diego; 150+ expert speakers; 5 tracks & 8 workshops; 1,900+ attendees with networking opportunities; Advanced technology showcases. Save 10% with VERTMARKETS at Checkout.